rs183898

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003060.4(SLC22A5):​c.497+2729C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.286 in 152,100 control chromosomes in the GnomAD database, including 6,960 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6959 hom., cov: 32)
Exomes 𝑓: 0.50 ( 1 hom. )

Consequence

SLC22A5
NM_003060.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.373

Publications

14 publications found
Variant links:
Genes affected
SLC22A5 (HGNC:10969): (solute carrier family 22 member 5) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
SLC22A5 Gene-Disease associations (from GenCC):
  • systemic primary carnitine deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • short QT syndrome
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.543 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC22A5NM_003060.4 linkc.497+2729C>G intron_variant Intron 2 of 9 ENST00000245407.8 NP_003051.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC22A5ENST00000245407.8 linkc.497+2729C>G intron_variant Intron 2 of 9 1 NM_003060.4 ENSP00000245407.3

Frequencies

GnomAD3 genomes
AF:
0.286
AC:
43540
AN:
151976
Hom.:
6958
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.167
Gnomad AMI
AF:
0.130
Gnomad AMR
AF:
0.289
Gnomad ASJ
AF:
0.300
Gnomad EAS
AF:
0.375
Gnomad SAS
AF:
0.559
Gnomad FIN
AF:
0.429
Gnomad MID
AF:
0.415
Gnomad NFE
AF:
0.311
Gnomad OTH
AF:
0.288
GnomAD4 exome
AF:
0.500
AC:
3
AN:
6
Hom.:
1
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
2
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.500
AC:
1
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
1.00
AC:
2
AN:
2
Other (OTH)
AF:
0.00
AC:
0
AN:
2
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.286
AC:
43551
AN:
152094
Hom.:
6959
Cov.:
32
AF XY:
0.299
AC XY:
22203
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.167
AC:
6931
AN:
41488
American (AMR)
AF:
0.289
AC:
4423
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.300
AC:
1040
AN:
3472
East Asian (EAS)
AF:
0.376
AC:
1948
AN:
5176
South Asian (SAS)
AF:
0.560
AC:
2700
AN:
4820
European-Finnish (FIN)
AF:
0.429
AC:
4521
AN:
10544
Middle Eastern (MID)
AF:
0.395
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
0.311
AC:
21144
AN:
67982
Other (OTH)
AF:
0.288
AC:
609
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1534
3069
4603
6138
7672
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
446
892
1338
1784
2230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.206
Hom.:
612
Bravo
AF:
0.263
Asia WGS
AF:
0.463
AC:
1610
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.4
DANN
Benign
0.71
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183898; hg19: chr5-131716902; API